33
mouse embryos and embryoid bodies. Arteriosclerosis, Thrombosis, and Vascular Biology,
22, 927–933.
43. Galabova-Kovacs, G., Matzen, D., Piazzolla, D., Meissl, K., Plyushch, T., Chen, A. P., et al.
(2006). Essential role of B-Raf in ERK activation during extraembryonic development.
Proceedings of the National Academy of Sciences of the United States of America, 103,
1325–1330.
44. Galan Moya, E. M., Le Guelte, A., & Gavard, J. (2009). PAKing up to the endothelium.
Cellular Signalling, 21, 1727–1737.
45. Gao, M., Craig, D., Lequin, O., Campbell, I. D., Vogel, V., & Schulten, K. (2003). Structure
and functional significance of mechanically unfolded fibronectin type III1 intermediates.
Proceedings of the National Academy of Sciences of the United States of America, 100,
14784–14789.
46. Gerety, S. S., & Anderson, D. J. (2002). Cardiovascular ephrinB2 function is essential for
embryonic angiogenesis. Development, 129, 1397–1410.
47. Gill, S. E., & Parks, W. C. (2008). Metalloproteinases and their inhibitors: Regulators of
wound healing. The International Journal of Biochemistry & Cell Biology, 40, 1334–1347.
48. Greenberg, J. I., Shields, D. J., Barillas, S. G., Acevedo, L. M., Murphy, E., Huang, J., et al.
(2008). A role for VEGF as a negative regulator of pericyte function and vessel maturation.
Nature, 456, 809–813.
49. Hall, A. (2005). Rho GTPases and the control of cell behaviour. Biochemical Society
Transactions, 33, 891–895.
50. Hallmann, R., Horn, N., Selg, M., Wendler, O., Pausch, F., & Sorokin, L. M. (2005).
Expression and function of laminins in the embryonic and mature vasculature. Physiological
Reviews, 85, 979–1000.
51. Hammes, H. P. (2005). Pericytes and the pathogenesis of diabetic retinopathy. Hormone and
Metabolic Research, 37(Suppl 1), 39–43.
52. Handsley, M. M., & Edwards, D. R. (2005). Metalloproteinases and their inhibitors in tumor
angiogenesis. International Journal of Cancer, 115, 849–860.
53. Herbert, S. P., Huisken, J., Kim, T. N., Feldman, M. E., Houseman, B. T., Wang, R. A., et al.
(2009). Arterial-venous segregation by selective cell sprouting: An alternative mode of blood
vessel formation. Science (New York, N.Y.), 326, 294–298.
54. Hirschi, K. K., Rohovsky, S. A., & D'Amore, P. A. (1998). PDGF, TGF-beta, and heterotypic
cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their
differentiation to a smooth muscle fate. The Journal of Cell Biology, 141, 805–814.
55. Holderfield, M. T., & Hughes, C. C. (2008). Crosstalk between vascular endothelial growth
factor, notch, and transforming growth factor-beta in vascular morphogenesis. Circulation
Research, 102, 637–652.
56. Hughes, C. C. (2008). Endothelial-stromal interactions in angiogenesis. Current Opinion in
Hematology, 15, 204–209.
57. Hynes, R. O. (2007). Cell-matrix adhesion in vascular development. Journal of Thrombosis
and Haemostasis, 5(Suppl 1), 32–40.
58. Hynes, R. O. (2009). The extracellular matrix: Not just pretty fibrils. Science (New York,
N.Y.), 326, 1216–1219.
59. Ingram, K. G., Curtis, C. D., Silasi-Mansat, R., Lupu, F., & Griffin, C. T. (2013). The NuRD
chromatin-remodeling enzyme CHD4 promotes embryonic vascular integrity by transcriptionally regulating extracellular matrix proteolysis. PLoS Genetics, 9, e1004031. https://doi.
org/10.1371/journal.pgen.1004031
60. Iruela-Arispe, M. L., & Davis, G. E. (2009). Cellular and molecular mechanisms of vascular
lumen formation. Developmental Cell, 16, 222–231.
61. Jain, R. K. (2005). Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science (New York, N.Y.), 307, 58–62.
62. Kamei, M., Saunders, W. B., Bayless, K. J., Dye, L., Davis, G. E., & Weinstein, B. M. (2006).
Endothelial tubes assemble from intracellular vacuoles in vivo. Nature, 442, 453–456.
1 Molecular Control of Capillary Tube Morphogenesis and Maturation Through…
mouse embryos and embryoid bodies. Arteriosclerosis, Thrombosis, and Vascular Biology,
22, 927–933.
43. Galabova-Kovacs, G., Matzen, D., Piazzolla, D., Meissl, K., Plyushch, T., Chen, A. P., et al.
(2006). Essential role of B-Raf in ERK activation during extraembryonic development.
Proceedings of the National Academy of Sciences of the United States of America, 103,
1325–1330.
44. Galan Moya, E. M., Le Guelte, A., & Gavard, J. (2009). PAKing up to the endothelium.
Cellular Signalling, 21, 1727–1737.
45. Gao, M., Craig, D., Lequin, O., Campbell, I. D., Vogel, V., & Schulten, K. (2003). Structure
and functional significance of mechanically unfolded fibronectin type III1 intermediates.
Proceedings of the National Academy of Sciences of the United States of America, 100,
14784–14789.
46. Gerety, S. S., & Anderson, D. J. (2002). Cardiovascular ephrinB2 function is essential for
embryonic angiogenesis. Development, 129, 1397–1410.
47. Gill, S. E., & Parks, W. C. (2008). Metalloproteinases and their inhibitors: Regulators of
wound healing. The International Journal of Biochemistry & Cell Biology, 40, 1334–1347.
48. Greenberg, J. I., Shields, D. J., Barillas, S. G., Acevedo, L. M., Murphy, E., Huang, J., et al.
(2008). A role for VEGF as a negative regulator of pericyte function and vessel maturation.
Nature, 456, 809–813.
49. Hall, A. (2005). Rho GTPases and the control of cell behaviour. Biochemical Society
Transactions, 33, 891–895.
50. Hallmann, R., Horn, N., Selg, M., Wendler, O., Pausch, F., & Sorokin, L. M. (2005).
Expression and function of laminins in the embryonic and mature vasculature. Physiological
Reviews, 85, 979–1000.
51. Hammes, H. P. (2005). Pericytes and the pathogenesis of diabetic retinopathy. Hormone and
Metabolic Research, 37(Suppl 1), 39–43.
52. Handsley, M. M., & Edwards, D. R. (2005). Metalloproteinases and their inhibitors in tumor
angiogenesis. International Journal of Cancer, 115, 849–860.
53. Herbert, S. P., Huisken, J., Kim, T. N., Feldman, M. E., Houseman, B. T., Wang, R. A., et al.
(2009). Arterial-venous segregation by selective cell sprouting: An alternative mode of blood
vessel formation. Science (New York, N.Y.), 326, 294–298.
54. Hirschi, K. K., Rohovsky, S. A., & D'Amore, P. A. (1998). PDGF, TGF-beta, and heterotypic
cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their
differentiation to a smooth muscle fate. The Journal of Cell Biology, 141, 805–814.
55. Holderfield, M. T., & Hughes, C. C. (2008). Crosstalk between vascular endothelial growth
factor, notch, and transforming growth factor-beta in vascular morphogenesis. Circulation
Research, 102, 637–652.
56. Hughes, C. C. (2008). Endothelial-stromal interactions in angiogenesis. Current Opinion in
Hematology, 15, 204–209.
57. Hynes, R. O. (2007). Cell-matrix adhesion in vascular development. Journal of Thrombosis
and Haemostasis, 5(Suppl 1), 32–40.
58. Hynes, R. O. (2009). The extracellular matrix: Not just pretty fibrils. Science (New York,
N.Y.), 326, 1216–1219.
59. Ingram, K. G., Curtis, C. D., Silasi-Mansat, R., Lupu, F., & Griffin, C. T. (2013). The NuRD
chromatin-remodeling enzyme CHD4 promotes embryonic vascular integrity by transcriptionally regulating extracellular matrix proteolysis. PLoS Genetics, 9, e1004031. https://doi.
org/10.1371/journal.pgen.1004031
60. Iruela-Arispe, M. L., & Davis, G. E. (2009). Cellular and molecular mechanisms of vascular
lumen formation. Developmental Cell, 16, 222–231.
61. Jain, R. K. (2005). Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science (New York, N.Y.), 307, 58–62.
62. Kamei, M., Saunders, W. B., Bayless, K. J., Dye, L., Davis, G. E., & Weinstein, B. M. (2006).
Endothelial tubes assemble from intracellular vacuoles in vivo. Nature, 442, 453–456.
1 Molecular Control of Capillary Tube Morphogenesis and Maturation Through…